Peritoneal Cancers and Hyperthermic Intraperitoneal Chemotherapy.
Colorectal
Cytoreductive surgery
Hyperthermic intraperitoneal chemotherapy
Ovarian cancer
Peritoneal carcinoma index
Peritoneal mesothelioma
Peritoneal metastasis
Pseudomyxoma peritonei
Journal
The Surgical clinics of North America
ISSN: 1558-3171
Titre abrégé: Surg Clin North Am
Pays: United States
ID NLM: 0074243
Informations de publication
Date de publication:
Jun 2020
Jun 2020
Historique:
entrez:
14
5
2020
pubmed:
14
5
2020
medline:
10
6
2020
Statut:
ppublish
Résumé
Cytoreductive surgery followed by hyperthermic intraperitoneal chemotherapy is an aggressive, potentially curative approach used to treat locoregional disease associated with primary and secondary malignancies of the peritoneum. It involves resection of all macroscopic disease larger than 2.5 mm, followed by instillation of hyperthermic chemotherapy directly into the peritoneum for higher drug exposure to microscopic disease. In select patients with primary peritoneal mesothelioma, pseudomyxoma peritonei, colorectal adenocarcinoma, appendiceal adenocarcinoma, or ovarian cancer, with no extra-abdominal metastasis and limited involvement of the peritoneum, the procedure can be performed to increase overall survival.
Identifiants
pubmed: 32402303
pii: S0039-6109(20)30022-0
doi: 10.1016/j.suc.2020.02.009
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
589-613Informations de copyright
Copyright © 2020 Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Disclosure No financial conflicts of interest to disclose.